The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Lewicki John A. since 2014.
This trader's CIK number is 1553352.
At the time of last reporting, Lewicki John A. was the Chief Scientific Officer of Mereo Biopharma Group Plc. (stock ticker symbol MREO).
Also see all insider trading activities at Mereo Biopharma Group Plc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | MREO | 0 | $0 | 40,373 | $153,901 | 115,000 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | OMED | 0 | $0 | 8,009 | $19,414 | 0 | $0 |
| 2017 | OMED | 0 | $0 | 16,177 | $126,919 | 9,175 | $13,120 |
| 2016 | OMED | 0 | $0 | 2,162 | $47,416 | 0 | $0 |
| 2015 | OMED | 0 | $0 | 42,000 | $1,036,519 | 42,000 | $68,517 |
| 2014 | OMED | 0 | $0 | 28,000 | $605,070 | 28,000 | $40,039 |
1. Mereo Biopharma Group Plc (MREO)
2. Oncomed Pharmaceuticals Inc (OMED)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-09-13 | MREO | Sale | 10,937 | 4.22 | 46,165 |
| 2024-09-12 | MREO | Sale | 5,212 | 4.47 | 23,313 |
| 2024-09-11 | MREO | Option Ex | 46,000 | .00 | 0 |
| 2024-06-25 | MREO | Sale | 7,416 | 3.69 | 27,394 |
| 2024-06-26 | MREO | Sale | 16,808 | 3.39 | 57,029 |
| 2024-06-21 | MREO | Option Ex | 69,000 | .00 | 0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-10-10 | OMED | Sale | 1,156 | 2.01 | 2,323 |
| 2018-10-09 | OMED | Sale | 2,296 | 2.13 | 4,888 |
| 2018-04-24 | OMED | Sale | 4,557 | 2.68 | 12,203 |
| 2017-10-10 | OMED | Sale | 1,248 | 4.25 | 5,305 |
| 2017-04-04 | OMED | Sale | 5,754 | 8.96 | 51,573 |
| 2017-01-03 | OMED | Option Ex | 9,175 | 1.43 | 13,120 |
| 2017-01-03 | OMED | Sale | 9,175 | 7.63 | 70,041 |
| 2016-01-06 | OMED | Sale | 2,161 | 21.93 | 47,395 |
| 2016-01-07 | OMED | Sale | 1 | 21.33 | 21 |
| 2015-06-15 | OMED | Option Ex | 8,500 | 1.43 | 12,155 |
| 2015-06-16 | OMED | Option Ex | 8,500 | 2.42 | 20,612 |
| 2015-06-15 | OMED | Sale | 8,500 | 24.92 | 211,794 |
| 2015-06-16 | OMED | Sale | 8,500 | 25.22 | 214,336 |
| 2015-04-01 | OMED | Option Ex | 8,500 | 1.43 | 12,155 |
| 2015-04-02 | OMED | Option Ex | 8,500 | 1.43 | 12,155 |
| 2015-04-01 | OMED | Sale | 8,500 | 25.19 | 214,106 |
| 2015-04-02 | OMED | Sale | 8,500 | 25.49 | 216,699 |
| 2015-02-02 | OMED | Sale | 4,000 | 22.49 | 89,952 |
| 2015-02-02 | OMED | Option Ex | 4,000 | 1.43 | 5,720 |
| 2015-01-02 | OMED | Option Ex | 4,000 | 1.43 | 5,720 |
| 2015-01-02 | OMED | Sale | 4,000 | 22.41 | 89,632 |
| 2014-12-01 | OMED | Option Ex | 4,000 | 1.43 | 5,720 |
| 2014-12-01 | OMED | Sale | 4,000 | 21.19 | 84,752 |
| 2014-11-03 | OMED | Sale | 4,000 | 20.45 | 81,820 |
| 2014-11-03 | OMED | Option Ex | 4,000 | 1.43 | 5,720 |
| 2014-10-02 | OMED | Sale | 5,809 | 20.00 | 116,180 |
| 2014-10-02 | OMED | Option Ex | 5,809 | 1.43 | 8,306 |
| 2014-09-02 | OMED | Sale | 2,191 | 20.00 | 43,830 |
| 2014-09-02 | OMED | Option Ex | 2,191 | 1.43 | 3,133 |
| 2014-08-01 | OMED | Sale | 4,000 | 20.98 | 83,912 |
| 2014-08-01 | OMED | Option Ex | 4,000 | 1.43 | 5,720 |
| 2014-07-01 | OMED | Option Ex | 4,000 | 1.43 | 5,720 |
| 2014-07-01 | OMED | Sale | 4,000 | 24.06 | 96,228 |
| 2014-06-16 | OMED | Option Ex | 4,000 | 1.43 | 5,720 |
| 2014-06-16 | OMED | Sale | 4,000 | 24.59 | 98,348 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lewicki John A. (Chief Scientific Officer of Mereo Biopharma Group Plc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.